Related Experiment Video
Updated: Feb 23, 2026

09:05
Meal Duration as a Measure of Orofacial Nociceptive Responses in Rodents
Published on: January 10, 2014
8.0K
Effects of High-Dose Capsaicin on TMD Subjects: A Randomized Clinical Study.
B K Campbell1, R B Fillingim2, S Lee3
1Magnolia Orthodontics, Hickory, NC, USA.
JDR Clinical and Translational Research
|September 8, 2017
Summary
High-concentration capsaicin cream effectively reduced temporomandibular joint disorder (TMD) pain. This novel topical therapy offers a safe and simple new treatment option for orofacial pain relief in TMD patients.
Area of Science:
- Neurology
- Pain Management
- Dermatology
Background:
- Temporomandibular joint disorder (TMD) causes significant orofacial pain and limited jaw function.
- Existing TMD treatments are limited, necessitating novel therapeutic approaches.
- TRP vanilloid subfamily member 1 (TRPV1) is a potential target for pain control.
Purpose of the Study:
- To evaluate the efficacy and safety of 8% topical capsaicin cream for TMD pain relief.
- To investigate capsaicin's effect on pain perception and sensory thresholds in TMD patients.
- To explore capsaicin's potential as a novel treatment targeting TRPV1 in TMD.
Main Methods:
- A double-blind, vehicle-controlled clinical trial was conducted.
- Participants received either 8% capsaicin cream or a vehicle control.
- Quantitative sensory testing (QST) and visual analog scale (VAS) for pain were used.
Main Results:
- TMD subjects treated with capsaicin reported significantly lower pain intensity one week post-application.
- A temporary decrease in thermal pain threshold was observed shortly after capsaicin application in both groups.
- Capsaicin did not affect pressure pain threshold or mechanical sensitivity.
Conclusions:
- 8% topical capsaicin is a safe, simple, and effective treatment for TMD pain.
- Targeting TRPV1 with capsaicin offers a promising new avenue for managing orofacial pain in TMD.
- This study provides evidence for capsaicin as an additional therapeutic option for TMD patients.

